Department of Pediatrics, Khoula hospital, Muscat, Oman.
Department of Statistics, OMSB, Muscat, Oman.
Am J Perinatol. 2024 May;41(S 01):e747-e754. doi: 10.1055/a-1933-0104. Epub 2022 Aug 29.
The overuse of antimicrobials in neonates is not uncommon and has resulted in a global health crisis of antibiotic resistance. This study aimed to evaluate changes associated with a neonatologist-driven antimicrobial stewardship program (ASP) in antibiotic usage.
We conducted a pre-post retrospective cohort study in a tertiary care hospital in Oman. Neonates admitted in 2014 to 2015 were considered as the pre-ASP cohort. In 2016, a neonatologist-driven ASP was launched in the unit. The program included the optimization and standardization of antibiotic use for early- and late-onset sepsis using the Centers for Disease Control and Prevention's "broad principles," an advanced antimicrobial decision-support system to resolve contentious issues, and placed greater emphasis on education and behavior modification. Data from the years 2016 to 2019 were compared with previous data. The outcome of interest included days of therapy (DOT) for antimicrobials. Baseline characteristics and outcomes were compared using standard statistical measures.
The study included 2,098 neonates in the pre-ASP period and 5,464 neonates in the post-ASP period. There was no difference in baseline characteristics. The antibiotic use decreased from 752 DOT per 1,000 patient-days (PD) in the pre-ASP period to 264 DOT in the post-ASP period (64.8% reduction, < 0.001). The proportion of neonates who received any antibiotics declined by 46% (pre-ASP = 1,161/2,098, post-ASP = 1,676/5,464). The most statistically significant reduction in DOT per 1,000 PD was observed in the use of cefotaxime (82%), meropenem (74%), and piperacillin-tazobactam (74%). There was no change in mortality, culture-positive microbial profile, or multidrug-resistant organism incidence in the post-ASP period.
Empowering frontline neonatologists to drive ASPs was associated with a sustained reduction in antibiotic utilization.
· Overuse of antimicrobials is not uncommon in neonatal intensive care units.. · ASPs and infection control and prevention measures may help in decreasing antibiotic consumption and culture-positive sepsis.. · Empowering frontline neonatologists resulted in a sustained decrease in antimicrobial use without extra resources or financial burden..
新生儿过度使用抗菌药物的现象并不少见,这已导致了抗生素耐药性的全球健康危机。本研究旨在评估由新生儿科医生主导的抗菌药物管理项目(ASP)对抗菌药物使用相关变化的影响。
我们在阿曼的一家三级保健医院进行了一项回顾性队列研究。2014 年至 2015 年入院的新生儿被视为 ASP 前队列。2016 年,该科室推出了由新生儿科医生主导的 ASP。该项目包括使用疾病控制与预防中心的“广泛原则”优化和标准化早发性和晚发性败血症的抗生素使用,使用先进的抗菌药物决策支持系统解决有争议的问题,并更加注重教育和行为改变。将 2016 年至 2019 年的数据与之前的数据进行了比较。主要结局指标为抗菌药物治疗日(DOT)。使用标准统计方法比较了基线特征和结局。
ASP 前阶段纳入 2098 例新生儿,ASP 后阶段纳入 5464 例新生儿。两组的基线特征无差异。抗生素使用量从 ASP 前阶段的每 1000 个患者日(PD)752 个 DOT 减少至 ASP 后阶段的 264 个 DOT(减少 64.8%,<0.001)。接受任何抗生素治疗的新生儿比例下降了 46%(ASP 前阶段为 2098 例中的 1161 例,ASP 后阶段为 5464 例中的 1676 例)。每 1000 PD 的 DOT 减少最显著的是头孢噻肟(82%)、美罗培南(74%)和哌拉西林-他唑巴坦(74%)。ASP 后阶段的死亡率、培养阳性微生物谱或多重耐药菌发生率无变化。
授权一线新生儿科医生主导 ASP 可持续降低抗生素使用量。
·新生儿重症监护病房中抗菌药物过度使用并不少见。·抗菌药物管理项目和感染控制与预防措施可能有助于减少抗生素的消耗和培养阳性败血症。·授权一线新生儿科医生可在不增加额外资源或财务负担的情况下,持续减少抗菌药物的使用。